These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16584141)

  • 1. Quantitative measurement of indomethacin crystallinity in indomethacin-silica gel binary system using differential scanning calorimetry and X-ray powder diffractometry.
    Pan X; Julian T; Augsburger L
    AAPS PharmSciTech; 2006 Feb; 7(1):E11. PubMed ID: 16584141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative measurement of indomethacin crystallinity in indomethacin-silica gel binary system using differential scanning calorimetry and X-ray powder diffractometry.
    Pan X; Julian T; Augsburger L
    AAPS PharmSciTech; 2006 Mar; 7(1):E72-E78. PubMed ID: 28290026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the degree of indomethacin crystallinity by chemoinfometrical Fourier-transformed [corrected] near-infrared spectroscopy and conventional powder X-ray diffractometry.
    Otsuka M; Kato F; Matsuda Y
    AAPS PharmSci; 2000; 2(1):E9. PubMed ID: 11741225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.
    Kaminska E; Adrjanowicz K; Zakowiecki D; Milanowski B; Tarnacka M; Hawelek L; Dulski M; Pilch J; Smolka W; Kaczmarczyk-Sedlak I; Kaminski K
    Pharm Res; 2014 Oct; 31(10):2887-903. PubMed ID: 24831310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved physical stability of amorphous state through acid base interactions.
    Telang C; Mujumdar S; Mathew M
    J Pharm Sci; 2009 Jun; 98(6):2149-59. PubMed ID: 18837038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective colloids and polylactic acid co-affecting the polymorphic crystal forms and crystallinity of indomethacin encapsulated in microspheres.
    Lin SY; Chen KS; Teng HH
    J Microencapsul; 1999; 16(6):769-76. PubMed ID: 10575628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the dissolution rate of a low-solubility drug through a crystalline-amorphous transition: a case study with indomethacin [correction of indomethicin].
    Pan X; Julian T; Augsburger L
    Drug Dev Ind Pharm; 2008 Feb; 34(2):221-31. PubMed ID: 18302042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salt formation during freeze-drying--an approach to enhance indomethacin dissolution.
    Thakral S; Suryanarayanan R
    Pharm Res; 2015 Nov; 32(11):3722-31. PubMed ID: 26063046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the microcrystallinity of a drug substance, indomethacin, in a pharmaceutical model tablet by chemometric FT-Raman spectroscopy.
    Okumura T; Otsuka M
    Pharm Res; 2005 Aug; 22(8):1350-7. PubMed ID: 16078145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel standard sample powder preparation method for quantitative analysis of polymorphs.
    Okumura T; Otsuka M
    J Pharm Sci; 2005 May; 94(5):1013-23. PubMed ID: 15793799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy and conventional powder X-ray diffractometry.
    Otsuka M; Kato F; Matsuda Y
    Analyst; 2001 Sep; 126(9):1578-82. PubMed ID: 11592653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52.
    Wang X; de Armas HN; Blaton N; Michoel A; Van den Mooter G
    Int J Pharm; 2007 Dec; 345(1-2):95-100. PubMed ID: 17604923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gel Formation Induced Slow Dissolution of Amorphous Indomethacin.
    Heng W; Wei Y; Xue Y; Cheng H; Zhang L; Zhang J; Gao Y; Qian S
    Pharm Res; 2019 Sep; 36(11):159. PubMed ID: 31515697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
    Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
    J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation of indomethacin-nicotinamide cocrystal formation induced by thermal stress in the solid or liquid state.
    Lin HL; Zhang GC; Huang YT; Lin SY
    J Pharm Sci; 2014 Aug; 103(8):2386-95. PubMed ID: 24942554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of processing route on the surface properties of amorphous indomethacin measured by inverse gas chromatography.
    Burnett DJ; Khoo J; Naderi M; Heng JY; Wang GD; Thielmann F
    AAPS PharmSciTech; 2012 Dec; 13(4):1511-7. PubMed ID: 23135965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro and in vivo indomethacin release from self-setting bioactive glass bone cement.
    Otsuka M; Nakahigashi Y; Matsuda Y; Kokubo T; Yoshihara S; Fujita H; Nakamura T
    Biomed Mater Eng; 1997; 7(5):291-302. PubMed ID: 9457380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
    Priemel PA; Laitinen R; Grohganz H; Rades T; Strachan CJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of diffuse reflectance near-infrared spectroscopy for determination of crystallinity.
    Seyer JJ; Luner PE; Kemper MS
    J Pharm Sci; 2000 Oct; 89(10):1305-16. PubMed ID: 10980505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture.
    Padrela L; de Azevedo EG; Velaga SP
    Drug Dev Ind Pharm; 2012 Aug; 38(8):923-9. PubMed ID: 22092083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.